Related Experiment Videos
Leydig cell tumor in grey zone: A case report.
Muheilan Mustafa Muheilan1, Maha Shomaf2, Emad Tarawneh3
1Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Jordan.
International Journal of Surgery Case Reports
|April 19, 2017
Summary
Leydig cell tumors are rare testicular neoplasms. Early detection through ultrasound is increasing, and radical orchiectomy is the primary treatment, requiring careful long-term follow-up for potential metastasis.
Area of Science:
- Oncology
- Urology
Background:
- Leydig cell tumors represent 1-3% of testicular neoplasms.
- Increased incidence may be linked to enhanced early detection via ultrasound.
- This highlights the importance of recognizing and managing these rare tumors.
Purpose of the Study:
- To report a case of Leydig cell tumor with unusual presentation.
- To discuss the diagnostic and management strategies for testicular Leydig cell tumors.
- To emphasize the importance of long-term surveillance for potential recurrence or metastasis.
Main Methods:
- Case report of a patient with a Leydig cell tumor.
- Diagnostic workup included imaging (ultrasound, CT scans, chest radiography) and hormone assays.
- Management involved radical orchiectomy.
Main Results:
- Pathological diagnosis confirmed Leydig cell tumor.
- Staging workup revealed intrapulmonary nodule and enlarged retroperitoneal lymph nodes.
- The patient underwent radical orchiectomy for the scrotal mass.
Conclusions:
- Radical orchiectomy is the standard treatment for Leydig cell tumors.
- Regular follow-up (every 3-6 months) is crucial, including physical examination, hormone assays, and imaging.
- Careful monitoring for metastasis is recommended over immediate retroperitoneal lymph node dissection in ambiguous cases.